These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage. Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751 [TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome after kidney transplantation. Bellinghieri G; Bernardi A; Piva M; Pati T; Stoppa F; Scaramuzzo P; Garizzo O; Santoro D; Savica V; Bucciante G J Ren Nutr; 2009 Jan; 19(1):105-10. PubMed ID: 19121783 [TBL] [Abstract][Full Text] [Related]
4. Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation. Sui W; Zou H; Zou G; Yan Q; Chen H; Che W; Xie S Transpl Immunol; 2008 Nov; 20(1-2):95-8. PubMed ID: 18703143 [TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study. Fiuza M; Cortez-Dias N; Martins S; Belo A; Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993 [TBL] [Abstract][Full Text] [Related]
7. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney]. Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964 [TBL] [Abstract][Full Text] [Related]
15. [Cardioprotection: an essential component for predialysis chronic renal failure treatment]. Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513 [TBL] [Abstract][Full Text] [Related]
16. Renal manifestations in the metabolic syndrome. Locatelli F; Pozzoni P; Del Vecchio L J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254 [TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction. Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678 [TBL] [Abstract][Full Text] [Related]
18. [Left ventricular hypertrophy in chronic kidney disease]. Paoletti E; Cannella G G Ital Nefrol; 2006; 23(6):560-8. PubMed ID: 17173262 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of cardiovascular disease in chronic renal disease. Foley RN; Parfrey PS; Sarnak MJ J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763 [TBL] [Abstract][Full Text] [Related]
20. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions. Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]